ANIX Anixa Biosciences Inc
Company Analysis
Latest News
π’ Anixa Biosciences is trading 5% up in pre-market amid broader global risk-on sentiment
Anixa Biosciences is trading at $3.78, up 5.22%, amid broader global risk-on sentiment. - U.S. futures point higher; the Nasdaq Composite is up 0.62%. -...
Anixa's Vaccine Data Sparks a 9% Rally, but Can a Zero-Revenue Biotech Sustain the Momentum to Phase 2?
Shares of Anixa Biosciences surged 9.3% to $3.75 on August 19 after the company repackaged its strongest clinical data ahead of a marquee investor conference,...
π’ Anixa Biosciences is trading 9.33% up today after positive breast-cancer vaccine Phase 1 results
Anixa Biosciences is trading 9.33% up at $3.75 after positive breast-cancer vaccine Phase 1 results and encouraging ovarian-cancer CAR-T survival...
π΄ Anixa Biosciences is trading 8.31% down today in pre-market as risk-off sentiment pressures equities
Anixa Biosciences is trading 8.31% down in pre-market at $3.20, amid broader risk-off sentiment. - Closed at $3.49 on August 17, 2026, when it gained 9.75%. -...
π’ Anixa Biosciences is trading 10.06% up today, with no clear catalyst identified
Anixa Biosciences is trading 10.06% up at $3.50, but no clear company-specific catalyst has been identified for August 17, 2026. - CEO Amit Kumarβs purchase...
π’ Anixa Biosciences is trading 5.6% up today β no clear catalyst identified
Anixa Biosciences is trading 5.6% up now at $3.36, with no clear company-specific catalyst identified for August 17, 2026. - Recent coverage references CEO...
π’ Anixa Biosciences is trading 6.46% up in after-hours trading with no definitive catalyst identified
Anixa Biosciences is trading at $3.46 (+6.46%) in after-hours trading, with the move appearing speculative or liquidity-driven and no definitive catalyst...
π΄ Anixa Biosciences is trading 12% down today reversing an unexplained pre-market spike
Anixa Biosciences is trading at $3.00 (12% down) as the stock reverses a sharp, largely unexplained pre-market jump seen on August 03, 2026. β’ The move...
π’ Anixa Biosciences is trading 13.7% up today despite no clear company-specific catalyst
Anixa Biosciences is trading at $3.89 (+13.74%) in pre-market following a sharp overnight move with no fresh company-specific announcements identified. β’ The...
π΄ Anixa Biosciences is trading 6.1% down today amid biotech sector weakness
Anixa Biosciences is trading 6.1% down at $3.34 today, giving back a portion of its recent rebound as the broader biotech sector faces selling pressure. β’ The...
π’ Anixa Biosciences is trading 6.2% up today amid a broader market rebound
Anixa Biosciences is trading 6.2% up at $3.78 in pre-market, appearing to track a broader risk-on sentiment across U.S. equities. β’ The move extends a modest...
π’ Anixa Biosciences up 5.8% as CEO boosts stake and stock rebounds from pullback
β’ Anixa Biosciences' CEO Amit Kumar made recent significant insider purchases, acquiring thousands of shares on July 27 and July 24. β’ The stock is rebounding...
π΄ Anixa Biosciences is trading 6.5% down today on profit-taking after recent upgrade-driven rally
Anixa Biosciences is trading 6.5% down today at $3.46 as the stock undergoes consolidation following a significant rally last week. β’ The recent surge was...
Anixa Biosciences Upgraded to Strong Buy Following Narrower Quarterly Loss
Zacks Research upgraded Anixa Biosciences from a hold to a strong-buy recommendation. The upgrade follows the clinical-stage immuno-oncology company...
π’ Anixa Biosciences is trading 5.3% up today despite no clear catalyst
Anixa Biosciences is trading 5.3% up at $3.71 despite a lack of fresh company-specific news, regulatory updates, or analyst calls hitting the wires. β’ The...
π’ Anixa Biosciences is trading 6.1% up today amid a broader biotech rally and oncology pipeline optimism
Anixa Biosciences is trading 6.1% up at $3.67 today, driven by a broader biotech sector rally and positive sentiment surrounding its oncology pipeline. β’ The...
π’ Anixa Biosciences is trading 5.9% up today with no clear company-specific catalyst
Anixa Biosciences is trading at $3.60 (+5.88%) in pre-market following a modest late-week rebound despite a lack of fresh company-specific news. β’ The upward...
π’ Anixa Biosciences is trading 6.5% up today as it rebounds from recent biotech sector volatility
Anixa Biosciences is trading at $3.62 (6.5% up) in after-hours, rebounding from recent biotech-sector weakness and volatility earlier this week. β’ The move...
π΄ Anixa Biosciences is trading 7.6% down today amid broader biotech sector weakness
Anixa Biosciences is trading at $3.14 (7.6% down) in after-hours, reversing its 5.1% regular-session rebound as the broader biotech sector remains under...
π’ Anixa Biosciences is trading 5.1% up today, rebounding despite a broader biotech sector sell-off
Anixa Biosciences is trading 5.1% up today at $3.49, rebounding from a previous session drop despite a broader market downturn. β’ The stock is significantly...